Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,649
Total Claims
$551K
Drug Cost
561
Beneficiaries
$982
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-80%
Opioid rate vs peers
0.5% vs 2.2% avg
-30%
Cost per patient vs peers
$982 vs $1,411 avg
-8%
Brand preference vs peers
9.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.5%
Opioid Rate
58
Opioid Claims
$395
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,222 claims · $364K
Generic: 11,331 claims · $185K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 95 | $79K |
| Levothyroxine Sodium | 419 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 96 | $36K |
| Dapagliflozin Propanediol | 45 | $33K |
| Sitagliptin Phosphate | 39 | $27K |
| Insulin Nph Hum/Reg Insulin Hm | 46 | $17K |
| Rivaroxaban | 19 | $16K |
| Insulin Lispro | 27 | $14K |
| Sitagliptin Phos/Metformin Hcl | 19 | $13K |
| Losartan Potassium | 618 | $11K |
| Atorvastatin Calcium | 718 | $9,470 |
| Candesartan Cilexetil | 60 | $8,410 |
| Empagliflozin | 13 | $7,804 |
| Insulin Lispro Protamin/Lispro | 18 | $7,748 |
| Metoprolol Succinate | 318 | $6,350 |
Prescribing Profile
Patient Profile
76
Avg Age
58%
Female
1.84
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About